Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which hernia repair technique causes less pain? a trial puts two methods Head-to-Head

NCT ID NCT06367309

Disease control Sponsor: University Hospital, Basel, Switzerland Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial compares two minimally invasive surgical techniques for repairing ventral hernias (bulges in the abdominal wall). One technique, called eTEP, works entirely outside the abdominal cavity, while the other, IPOM, places a mesh inside the cavity. Researchers want to know which approach leads to less pain after surgery, fewer complications, and better long-term outcomes. The study includes adults with small-to-medium-sized hernias who are eligible for minimally invasive surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
two minimally invasive surgical techniques: Extended Totally Extraperitoneal (eTEP) repair and Intraperitoneal Onlay Mesh (IPOM) repair
What this could lead to
If one technique proves superior, it could become the preferred approach for ventral hernia repair, reducing patient pain and recovery time.
What could go wrong
This is a relatively small trial (138 participants), and results may not apply to all hernia types or patients. Both techniques carry standard surgical risks like infection or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 138 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2024

Expected to finish

Dec 2031

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient age \>18 years * Informed consent obtained * Primary or incisional ventral hernia * Epigastric, umbilical or infraumbilical ventral hernias with transversal diameter \>1cm and \</= 4cm, +/- rectus diastasis which doesn't demand specific treatment * If multiple hernias: cumulative transversal diameter \</= 4cm * Considered eligible for minimally-invasive approach Exclusion Criteria: * Subxyphoidal or suprapubic hernias * precedent hernia treatment with mesh placement in the retromuscular space * liver disease defined by the presence of ascites * end-stage renal disease requiring dialysis * need of an emergency surgery * pregnancy * need of rectus diastasis treatment intraoperatively Criteria for participating surgeons \- Each participating surgeon has performed 20 or more laparoscopic IPOM procedures and 20 or more eTEP procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Abdominal wall defect are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

abdominal wall malformation Hernia, Ventral

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Abdominal wall defect Ventral hernia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • St. Clara Hospital

    RECRUITING

    Basel, Canton of Basel-City, 4058, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.